Several other equities analysts have also weighed in on the stock. BMO Capital Markets cut their target price on shares of Humana from $490.00 to $415.00 in a report on Friday, January 7th. Sanford C. Bernstein decreased their price objective on shares of Humana from $470.00 to $431.00 in a research report on Tuesday, January 11th. Barclays dropped their target price on Humana from $540.00 to $490.00 and set an “overweight” rating on the stock in a research report on Friday, January 7th. The Goldman Sachs Group assumed coverage on Humana in a report on Tuesday, December 14th. They issued a “neutral” rating and a $472.00 price target for the company. Finally, Morgan Stanley lifted their price target on shares of Humana from $410.00 to $436.00 and gave the company an “equal weight” rating in a research note on Wednesday, March 9th. Seven equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $482.94.
Shares of Humana stock opened at $449.04 on Wednesday. The stock has a market cap of $56.91 billion, a PE ratio of 19.81, a price-to-earnings-growth ratio of 1.39 and a beta of 0.94. The firm has a fifty day moving average price of $434.16 and a 200 day moving average price of $430.60. Humana has a 1 year low of $351.20 and a 1 year high of $475.44. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.62 and a quick ratio of 1.62.
Large investors have recently modified their holdings of the business. BlackRock Inc. lifted its position in shares of Humana by 6.6% during the 4th quarter. BlackRock Inc. now owns 11,254,356 shares of the insurance provider’s stock worth $5,220,447,000 after purchasing an additional 693,945 shares during the last quarter. Wellington Management Group LLP grew its position in shares of Humana by 10.7% in the 3rd quarter. Wellington Management Group LLP now owns 6,465,032 shares of the insurance provider’s stock valued at $2,515,867,000 after buying an additional 626,652 shares during the last quarter. State Street Corp raised its stake in Humana by 0.3% during the 4th quarter. State Street Corp now owns 5,726,024 shares of the insurance provider’s stock worth $2,660,025,000 after acquiring an additional 15,994 shares in the last quarter. Capital Research Global Investors lifted its position in Humana by 49.5% in the fourth quarter. Capital Research Global Investors now owns 3,872,000 shares of the insurance provider’s stock valued at $1,796,075,000 after acquiring an additional 1,281,466 shares during the last quarter. Finally, Capital International Investors boosted its stake in Humana by 0.3% in the fourth quarter. Capital International Investors now owns 3,151,994 shares of the insurance provider’s stock valued at $1,462,210,000 after acquiring an additional 8,127 shares in the last quarter. Institutional investors own 92.96% of the company’s stock.
Humana Company Profile (Get Rating)
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
- Get a free copy of the StockNews.com research report on Humana (HUM)
- OrganiGram’s Turnaround Begins To Blossom
- Three Dividend Stocks With Growth Potential
- Exelon Stock Still Has Extraordinary Upside
- Greenbrier Companies Stock has Green in its Future
- Insiders Are Selling Palo Alto Networks
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.